Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Immunol., 03 November 2025

Sec. Mucosal Immunity

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1731676

This article is part of the Research TopicAdvances in Immunity and Strategies Against Mucosal Pathogen Colonization: Innovations in Immunogens and AdjuvantsView all articles

Correction: Discovery of protease inhibitors from bacteria as novel adjuvants for oral vaccine formulations

This article is a correction to:

  1. Discovery of protease inhibitors from bacteria as novel adjuvants for oral vaccine formulations

    1. Read original article
Lorena M. Coria,*Lorena M. Coria1,2*Celeste Pueblas Castro,Celeste Pueblas Castro1,2Laura Bruno,Laura Bruno1,2Helder I. Nakaya,,Helder I. Nakaya3,4,5Karina A. Pasquevich,Karina A. Pasquevich1,2Juliana Cassataro,*Juliana Cassataro1,2*
  • 1Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín (UNSAM) – Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina
  • 2Escuela de Bio y Nanotecnología (EByN), Universidad Nacional de San Martín, Buenos Aires, Argentina
  • 3Hospital Israelita Albert Einstein, São Paulo, Brazil
  • 4Institut Pasteur de São Paulo, São Paulo, Brazil
  • 5Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil

A Correction on
Discovery of protease inhibitors from bacteria as novel adjuvants for oral vaccine formulations

By Coria LM, Pueblas Castro C, Bruno L, Nakaya HI, Pasquevich KA and Cassataro J (2025) Front. Immunol. 16:1679540. doi: 10.3389/fimmu.2025.1679540

The title of this article was erroneously given as: “Discovery or protease inhibitors from bacteria as novel adjuvants for oral vaccine formulations”. The correct title of the article is “Discovery of protease inhibitors from bacteria as novel adjuvants for oral vaccine formulations”.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: protease inhibitor, mucosal adjuvant, oral delivery, antigen degradation, mucosal immunity

Citation: Coria LM, Pueblas Castro C, Bruno L, Nakaya HI, Pasquevich KA and Cassataro J (2025) Correction: Discovery of protease inhibitors from bacteria as novel adjuvants for oral vaccine formulations. Front. Immunol. 16:1731676. doi: 10.3389/fimmu.2025.1731676

Received: 24 October 2025; Accepted: 27 October 2025;
Published: 03 November 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Coria, Pueblas Castro, Bruno, Nakaya, Pasquevich and Cassataro. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Juliana Cassataro, anVjYXNzYXRhcm9AaWliLnVuc2FtLmVkdS5hcg==; Lorena M. Coria, bGNvcmlhQGlpYi51bnNhbS5lZHUuYXI=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.